Bio-Techne
TECH
#1477
Rank
HK$91.50 B
Marketcap
HK$575.90
Share price
-2.52%
Change (1 day)
29.16%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2024 : HK$3.10 Billion

According to Bio-Techne's latest financial reports the company's total debt is HK$3.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30HK$3.56 B39.44%
2022-06-30HK$2.55 B-21.66%
2021-06-30HK$3.26 B-2.83%
2020-06-30HK$3.35 B-14.87%
2019-06-30HK$3.94 B48.35%
2018-06-30HK$2.66 B-0.83%
2017-06-30HK$2.68 B262.99%
2016-06-30HK$0.73 B23.79%
2015-06-30HK$0.59 B495.01%
2014-06-30HK$0.10 B
2006-06-30HK$0.10 B-8.22%
2005-06-30HK$0.11 B-8.16%
2004-06-30HK$0.12 B-7.19%
2003-06-30HK$0.13 B-5.37%
2002-06-30HK$0.14 B-4.68%
2001-06-30HK$0.14 B-4.1%
2000-06-30HK$0.15 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
HK$274.74 B 8,752.20%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$10.79 B 247.97%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$150.33 B 4,743.85%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$136.34 B 4,292.88%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$10.90 B 251.36%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$155.00 B 4,894.01%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.3 M-99.12%๐Ÿ‡บ๐Ÿ‡ธ USA